Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study.
Autor: | Zimmermann M; Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.; Translational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada., Minuzzi L; Translational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Aliaga Aliaga A; Translational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada.; PET Unit, McConnell Brain Imaging Centre, Montréal, QC, Canada., Guiot MC; Department of Pathology, Montréal Neurological Institute, Montréal, QC, Canada., Hall JA; Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada., Soucy JP; Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.; PET Unit, McConnell Brain Imaging Centre, Montréal, QC, Canada., Massarweh G; PET Unit, McConnell Brain Imaging Centre, Montréal, QC, Canada., El Mestikawy S; Department of Psychiatry, Douglas Research Institute, McGill University, Montréal, QC, Canada., Rosa-Neto P; Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.; Translational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada., Kobayashi E; Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in neurology [Front Neurol] 2022 Jul 22; Vol. 13, pp. 888479. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022). |
DOI: | 10.3389/fneur.2022.888479 |
Abstrakt: | Abnormalities in the expression of metabotropic glutamate receptor type 5 (mGluR5) have been observed in the hippocampus of patients with drug-resistant mesial Temporal Lobe Epilepsy (mTLE). Ex-vivo studies in mTLE hippocampal surgical specimens have shown increased mGluR5 immunoreactivity, while in vivo whole brain imaging using positron emission tomography (PET) demonstrated reduced hippocampal mGluR5 availability. To further understand mGluR5 abnormalities in mTLE, we performed a saturation autoradiography study with [ 3 H]ABP688 (a negative mGluR5 allosteric modulator). We aimed to evaluate receptor density (B Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Zimmermann, Minuzzi, Aliaga Aliaga, Guiot, Hall, Soucy, Massarweh, El Mestikawy, Rosa-Neto and Kobayashi.) |
Databáze: | MEDLINE |
Externí odkaz: |